Wuxi Biologics Cayman - ADRWXXWY
13F holders, Q1 2024 (March 31)3holders
$3.59avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Wuxi Biologics Cayman - ADR (WXXWY) in their 13F filings. The largest holders were Rhumbline Advisers ($60K), PNC Financial Services Group, Inc. ($8K) and GAMMA Investing LLC ($22).
- Company
- Wuxi Biologics Cayman - ADR
- CUSIP
- 98260N108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $96K |
Ownership 3 holders
| Rhumbline Advisers | 0.00% | Add +1.1% | 16,738 | $60K |
| PNC Financial Services Group, Inc. | 0.00% | Add +37.7% | 2,145 | $8K |
| GAMMA Investing LLC | 0.00% | No change | 6 | $22 |
"% of holder's portfolio" is WXXWY's weight in each manager's 13F, not the share of Wuxi Biologics Cayman - ADR the manager owns.